Charles Clowes

CEO & Co-Founder

Charles Clowes, Co-Founder and Chief Science Officer at Precision Plants

About Charles

Commercially astute professional with extensive experience leading profitable growth across challenging omnichannel retail environments, regulated healthcare, novel biotech sectors and diverse SMEs—from Tesco to pioneering ventures in complex, compliance-driven industries. Brings strategic leadership and operational excellence to Precision Plants' mission of transforming British hemp through precision breeding.

Role at Precision Plants

Charles leads R&D strategy and has secured over £1M in non-dilutive funding from Innovate UK and University of Hertfordshire. As Home Office licence holder, he operates at the intersection of biotechnology, agriculture, and regulation, leading collaborations with University of Hertfordshire and Rothamsted Research to advance CRISPR-based hemp genetics for UK farmers.

Hemp & Cannabis Expertise

R&D strategy and academic collaborations (University of Hertfordshire, Rothamsted)
Regulatory compliance (Home Office, CQC, FSA)
Grant funding success (£1M+ from Innovate UK, 1 of 7 national winners)
Biotech and regulated healthcare sector leadership

Key Achievements

  • Secured £1M+ non-dilutive funding (1 of 7 national Innovate UK winners)
  • Home Office licence holder for hemp research
  • Director & Treasurer, Cannabis Industry Council (2021-2025)
  • Co-founded award-winning Bud & Tender CBD brand (FSA Novel Food listed)

Current Roles

CQC Registration & Patient Lead

Xen Health Clinics

2025-Present